Filing Details
- Accession Number:
- 0001562180-18-004844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 16:02:55
- Reporting Period:
- 2018-12-03
- Accepted Time:
- 2018-12-06 16:02:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1620368 | Victor Sandor | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-12-03 | 127,397 | $3.65 | 337,483 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-12-03 | 115,185 | $16.21 | 222,298 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-12-03 | 127,397 | $0.00 | 127,397 | $3.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
151,862 | 2024-09-22 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $16.00 to $16.435. Details of actual prices for shares sold are available from the Issuer upon request.
- The option vested in four equal annual installments beginning on September 22, 2015.